Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Bitcoin Gains Regulatory Ground as Crypto Rules Remain Unsettled for CLARITY Act

Bitcoin Gains Regulatory Ground as Crypto Rules Remain Unsettled for CLARITY Act

CoinspeakerCoinspeaker2026/08/28 10:51
By:Coinspeaker

In CLARITY Act news today, BlackRock head of digital assets Robert Mitchnick told CNBC on Wednesday that the CLARITY Act is less critical for Bitcoin than for the rest of the crypto market. He said Bitcoin had achieved a level of regulatory acceptance that most other digital assets had not.

His remarks came as US spot Bitcoin exchange-traded funds pulled in $232.1M on Wednesday, extending an eight-day inflow streak to $2.8Bn, according to CoinGlass.

Mitchnick’s comments drew a distinction between Bitcoin and areas such as decentralized finance (DeFi) and other complex crypto categories. For those areas, he said, the regulatory picture remains unsettled.

CLARITY Act News: Where the Bill Stands

H.R. 3633, the Digital Asset Market Clarity Act of 2025, passed the House of Representatives by a 294-134 vote on July 17, 2025, according to the congressional record.

The Senate Banking, Housing, and Urban Affairs Committee reported the measure with an amendment in the nature of a substitute on June 1, 2026. The Senate then received a motion for cloture and a motion to proceed to consideration of the measure on Aug. 8, 2026.

The bill has not passed the Senate. Its official title, as amended by the House, calls for a system of regulation for the offer and sale of digital commodities by the Securities and Exchange Commission and the Commodity Futures Trading Commission.

Why Bitcoin Is Treated as a Separate Case

For Bitcoin, Mitchnick said institutional investors were not banking on further legislation as part of their base case. In his framing, further regulatory progress would be potential upside rather than a requirement for Bitcoin.

He contrasted that position with DeFi and other complex crypto categories, where he said regulatory questions remain unsettled. The distinction places Bitcoin’s institutional position apart from the broader policy questions surrounding other parts of the digital-asset market.

Institutional Product Demand Beyond Bitcoin

Mitchnick said BlackRock’s IBIT continues to resonate with institutional investors, financial advisors, and direct investors. BlackRock has also extended its crypto product lineup to include Ethereum, with both non-staking and staking products, and added a Bitcoin premium-income product during the summer.

On stablecoins, Mitchnick said BlackRock is focused on growth beyond crypto trading, including cross-border payments and capital markets, with the implementation of the Genesis Act approaching.

Market Implications of the CLARITY Act News

Mitchnick attributed Bitcoin’s rally while equities struggled last week to distinct risk-and-return drivers rather than to equity-beta behavior.

He pointed to Bitcoin’s own flows and the debasement trade, while citing investor concerns about global debt and deficits. He also said younger demographics were increasingly favoring Bitcoin over gold as a store of value.

Spot Bitcoin ETFs recorded cumulative net inflows of $54.6Bn and total net assets of $98.6Bn, according to SoSoValue. In Mitchnick’s framing, the CLARITY Act is less central to Bitcoin’s current institutional case than it is to crypto categories where the regulatory picture remains unsettled.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

From Lowering Blood Sugar and Weight Loss to Cardiovascular Protection! Mounjaro Achieves "Cardiometabolic Leap," Lilly (LLY.US) Opens GLP-1's Second Growth Curve

Eli Lilly's diabetes drug Mounjaro has received approval in the United States for reducing the risk of serious cardiovascular disease. The U.S. Food and Drug Administration has approved Mounjaro for lowering cardiovascular risk in adults with type 2 diabetes who have established heart disease.

智通财经2026/08/28 12:36
From Lowering Blood Sugar and Weight Loss to Cardiovascular Protection! Mounjaro Achieves "Cardiometabolic Leap," Lilly (LLY.US) Opens GLP-1's Second Growth Curve